Hamilton's Pharmacopeia Season 3 Episode 3 Xenon: The Perfect Anesthetic?
- TVMA
- January 18, 2021
- 44 min
-
(27)
Xenon: The Perfect Anesthetic? is the third episode of season 3 of Hamilton's Pharmacopeia, a docuseries that explores the world of psychoactive substances and their impact on people and society. This episode focuses on Xenon, a rare and expensive gas that has been used as an anesthetic in medical settings and as a recreational drug in some parts of the world.
The host, journalist and chemist Hamilton Morris, travels to Germany to visit a company that produces Xenon for medical purposes. He learns about the properties and effects of Xenon, which include pain relief, sedation, and euphoria. He also meets with doctors who have used Xenon in surgery and with patients who have received Xenon as an alternative to traditional anesthesia.
Morris also delves into the history of Xenon as a recreational drug, which has been popular in Russia and other countries for its powerful and unique effects. He interviews users who describe their experiences with Xenon, which include hallucinations, out-of-body experiences, and intense feelings of joy and love.
Throughout the episode, Morris discusses the risks and benefits of Xenon use, both medically and recreationally. He talks with experts about the potential for addiction and long-term harm, as well as the ethical considerations of using a rare and expensive resource for recreational purposes.
The episode also features a segment on Xenon's potential applications in other fields, such as space travel and sports medicine. Morris talks with researchers who are exploring the use of Xenon to protect astronauts from radiation exposure and to enhance the recovery of athletes from injuries.
Overall, Xenon: The Perfect Anesthetic? provides a fascinating and informative look at one of the most intriguing psychoactive substances in the world. With its combination of science, history, and personal stories, this episode of Hamilton's Pharmacopeia is sure to captivate viewers and spark new discussions about the complex relationship between drugs and human experience.